Status:
COMPLETED
Evaluation and Treatment of Pediatric, Developmental, and Genetic Eye Diseases
Lead Sponsor:
National Eye Institute (NEI)
Conditions:
Eye Diseases
Eligibility:
All Genders
Brief Summary
This study will evaluate and treat children or adults with inherited or developmental eye conditions. It will allow specialists in pediatric ophthalmology, genetic ophthalmology, and ocular motility a...
Detailed Description
The purpose of this protocol is to allow the pediatric ophthalmology, genetic ophthalmology, and ocular motility specialists at the National Eye Institute to gain additional knowledge of the course of...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Subjects will be able to enroll if they:
- Are a pediatric patient, of any age, with ophthalmic conditions, especially inherited or developmental conditions, OR
- Are an adult patient with an eye disorder that began in childhood or that is likely to have a genetic/developmental component, OR
- Are an unaffected first-degree relative that we believe that will aid in our diagnosis or future research objectives, AND
- Have the ability to understand and sign an informed consent OR have a legal parent/guardian with the ability to do the same.
- EXCLUSION CRITERIA:
- Subjects will not be eligible if they:
- Are unable to follow-up as clinically indicated.
- Have a severe systemic disease that compromises our ability to provide adequate examination and/or treatment.
Exclusion
Key Trial Info
Start Date :
January 14 2004
Trial Type :
OBSERVATIONAL
End Date :
October 28 2008
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT00076271
Start Date
January 14 2004
End Date
October 28 2008
Last Update
July 2 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rocky Mountain Lions Eye Institute
Denver, Colorado, United States
2
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892